Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025)

Stoke Therapeutics (STOK) has 2 years of Treasury Shares data on record, last reported at $1.2 million in Q4 2024.

  • For Q4 2024, Treasury Shares fell 19.18% year-over-year to $1.2 million; the TTM value through Dec 2024 reached $1.2 million, down 19.18%, while the annual FY2024 figure was $1.2 million, 19.18% down from the prior year.
  • Treasury Shares reached $1.2 million in Q4 2024 per STOK's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.5 million in Q4 2023 and bottomed at $1.2 million in Q4 2024.